Latest News Wound care company NoBACZ Healthcare Ltd announces £2.7m seed round

Cambridge Enterprise portfolio company NoBACZ Healthcare Ltd closes £2.7m seed round to launch wound protection solution for dairy and beef cattle

NoBACZ Healthcare Ltd., a spin out from the University of Cambridge Department of Veterinary Medicine, is pleased to announce it has closed a £2.7m seed round led by The Yield Lab in conjunction with Innovate UK’s Combined Investor Partnership. Additional new investors include the Cambridge & Peterborough Combined Authority and several angel investors. Existing shareholders Cambridge Enterprise, Martlet Capital and the Cambridge Angels participated in this round.

Launched in 2019, NoBACZ is poised to disrupt the wound care market in animals and, downstream, in humans. The company leverages cutting edge science to enable natural, food-grade ingredients to produce a ‘better bandage’ that covers difficult-to-treat wounds in difficult-to-dress areas of the body. The result is a range of highly differentiated, sustainable and antimicrobial liquid barrier dressings that provide unsurpassed wound coverage while reducing the need for antibiotics.

Funding from this round will see NoBACZ launch its first product aimed at solving wound protection challenges in dairy and beef cattle. The funding will also enable the expansion of the company’s commercial and R&D teams, and the development of wound dressing solutions specific to the needs of horses and companion animals.

Traditional bandages are often awkward to apply, become contaminated with water, detritus, and bacteria and then go to landfill or incineration. We wanted to change that paradigm by providing a product that was environmentally friendly and convenient to apply whilst reducing antibiotic use and improving animal welfare. NoBACZ’s liquid bandages set in wet or dry conditions, form a robust but flexible barrier, and self-degrade, negating the time-intense activity of bandage removal. We believe that the NoBACZ solution offers the ideal product-market-fit by providing a better bandage that also just so happens to be green.

Dr Jonathan Powell, CEO, NoBACZ

This is really pioneering technology in a sector of our economy the Combined Authority is working to support. Our region’s mix of academia, R&D and entrepreneurship is part of what makes Cambridgeshire and Peterborough’s economy so exciting and I’m pleased Combined Authority seed funding has helped give NoBACZ the capital it needs to take its innovative technology to next level by launching its first product commercially.

Richard Kenny, Combined Authority Executive Director for Economy and Growth
Tags: , , , , , , , , , , , , , ,